....those who chose gemcitabine-based chemotherapy survived more than three times as long (14.0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment.
Pancreatic Proteolytic Enzyme Therapy Fails To Increase Survival or Quality of Life Compared to Conventional Gemcitabine Cytotoxic Therapy.....those who chose gemcitabine-based chemotherapy survived more than three times as long (14.0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment. |
||
|
||
| Page 1 of 4 |